Beurer IH 57 Gebrauchsanweisung Seite 38

• The local bioavailability of the medication is significantly increased
• Systemic diffusion is reduced substantially
• Only very low doses of the medication are required
• Quick and effective therapeutic effect
• Side effects are significantly reduced compared to systemic administration
• Humidification of the airways
• Loosening and making (bronchial) secretions more liquid
• Releasing bronchospasms (spasmolysis)
• Relieving swollen and inflamed bronchial mucosa
• Coughing up secretions
• Fighting viruses that affect the upper and lower airways
Indication
The nebuliser can be used for diseases of the upper and/or lower airways.
Examples of upper respiratory system diseases include:
• Nasal mucosal inflammation
• Allergic nasal mucosal inflammation
• Nasal sinus infection
• Pharyngitis
• Laryngitis
Examples of lower respiratory system diseases include:
• Bronchial asthma
• Bronchitis
• COPD (chronic obstructive pulmonary disease)
• Bronchiectasis
• Acute tracheobronchitis
• Cystic fibrosis
• Pneumonia
38